📊 STSSW Key Takeaways
Is Sharps Technology Inc. (STSSW) a Good Investment?
Sharps Technology is operationally non-viable with revenue of $204.1K generating losses of $282.5M, indicating fundamental business failure or incomplete commercialization. Despite a solvent balance sheet, negative unit economics (-202.5% gross margin) and $11M annual cash burn demonstrate the company cannot sustain operations without dramatic operational restructuring or exogenous capital infusions.
Why Buy Sharps Technology Inc. Stock? STSSW Key Strengths
- No long-term debt provides financial flexibility and eliminates solvency risk
- Strong balance sheet with $264.4M stockholders equity and $10.4M cash reserves
- Positive current ratio of 4.02x indicates short-term liquidity to fund operations
STSSW Stock Risks: Sharps Technology Inc. Investment Risks
- Catastrophic operating losses of $269.7M on $204.1K revenue indicates failed unit economics or pre-commercial state
- Negative gross margin of -202.5% demonstrates products lose money on every sale
- Negative operating cash flow of -$11M annually with free cash flow of -$14.4M creates unsustainable burn trajectory
Key Metrics to Watch
- Revenue acceleration and path to gross margin profitability
- Operating cash flow inflection point to positive territory
- Cash runway depletion rate given current $10.4M balance and $14.4M FCF burn
Sharps Technology Inc. (STSSW) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 4.02x current ratio provides a solid financial cushion.
STSSW Profit Margin, ROE & Profitability Analysis
STSSW vs Healthcare Sector: How Sharps Technology Inc. Compares
How Sharps Technology Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Sharps Technology Inc. Stock Overvalued? STSSW Valuation Analysis 2026
Based on fundamental analysis, Sharps Technology Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Sharps Technology Inc. Balance Sheet: STSSW Debt, Cash & Liquidity
STSSW Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Sharps Technology Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-2,219.92 indicates the company is currently unprofitable.
STSSW Revenue Growth, EPS Growth & YoY Performance
STSSW Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $83.6K | -$982.4K | $-4.33 |
| Q2 2025 | $222.7K | -$982.4K | $3.58 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Sharps Technology Inc. Dividends, Buybacks & Capital Allocation
STSSW SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Sharps Technology Inc. (CIK: 0001737995)
📋 Recent SEC Filings
❓ Frequently Asked Questions about STSSW
What is the AI rating for STSSW?
Sharps Technology Inc. (STSSW) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are STSSW's key strengths?
Claude: No long-term debt provides financial flexibility and eliminates solvency risk. Strong balance sheet with $264.4M stockholders equity and $10.4M cash reserves.
What are the risks of investing in STSSW?
Claude: Catastrophic operating losses of $269.7M on $204.1K revenue indicates failed unit economics or pre-commercial state. Negative gross margin of -202.5% demonstrates products lose money on every sale.
What is STSSW's revenue and growth?
Sharps Technology Inc. reported revenue of $204.1K.
Does STSSW pay dividends?
Sharps Technology Inc. does not currently pay dividends.
Where can I find STSSW SEC filings?
Official SEC filings for Sharps Technology Inc. (CIK: 0001737995) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is STSSW's EPS?
Sharps Technology Inc. has a diluted EPS of $-11.16.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is STSSW a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Sharps Technology Inc. has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is STSSW stock overvalued or undervalued?
Valuation metrics for STSSW: ROE of -106.9% (sector avg: 15%), net margin of -138,400.0% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy STSSW stock in 2026?
Our dual AI analysis gives Sharps Technology Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is STSSW's free cash flow?
Sharps Technology Inc.'s operating cash flow is $-11.0M, with capital expenditures of $3.4M. FCF margin is -7,051.0%.
How does STSSW compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -138,400.0% (avg: 12%), ROE -106.9% (avg: 15%), current ratio 4.02 (avg: 2).